oxyquinoline has been researched along with Cancer of Ovary in 3 studies
Oxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One approach in the treatment of ovarian cancer patients involves the infusion of autologous T lymphocytes coupled with a bispecific monoclonal antibody MOv18/anti-CD3 (biMAb OC/TR), which recognizes a 38-kDa glycoprotein expressed on ovarian carcinomas and the CD3 T cell receptor." | 1.30 | Comparison of three different methods for radiolabelling human activated T lymphocytes. ( Arienti, F; Bogni, A; Bombardieri, E; Botti, C; Canevari, S; Crippa, F; Lombardo, C; Maffioli, L; Massaron, S; Negri, DR; Nerini-Molteni, S; Pascali, C; Ramakrishna, V; Remonti, F; Seregni, E, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botti, C | 1 |
| Negri, DR | 1 |
| Seregni, E | 1 |
| Ramakrishna, V | 1 |
| Arienti, F | 1 |
| Maffioli, L | 1 |
| Lombardo, C | 1 |
| Bogni, A | 1 |
| Pascali, C | 1 |
| Crippa, F | 1 |
| Massaron, S | 1 |
| Remonti, F | 1 |
| Nerini-Molteni, S | 1 |
| Canevari, S | 1 |
| Bombardieri, E | 1 |
| Volfson, NI | 1 |
| Vol'fson, NI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the CIRCULATE Catheter for Transcoronary Administration of Pharmacologic and Cell-based Agents[NCT04703751] | 10 participants (Anticipated) | Interventional | 2022-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for oxyquinoline and Cancer of Ovary
| Article | Year |
|---|---|
Comparison of three different methods for radiolabelling human activated T lymphocytes.
Topics: Cell Death; Cell Survival; Cells, Cultured; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeox | 1997 |
On the genesis of granulosa-cell ovarian tumors. Experimental data.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Granulosa Cell Tumor; Hexestrol; Mic | 1976 |
[The genesis of experimental granulosa cell tumors of the ovaries].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Granulosa Cell Tumor; Hexestrol; Mic | 1976 |